BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 34 filers reported holding BIOLINERX LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $33,000 | -65.3% | 76,366 | -26.1% | 0.01% | +50.0% |
| Q4 2016 | $95,000 | -18.8% | 103,290 | +1.9% | 0.01% | -27.3% |
| Q3 2016 | $117,000 | +48.1% | 101,390 | +2.8% | 0.01% | 0.0% |
| Q2 2016 | $79,000 | -21.8% | 98,647 | -0.3% | 0.01% | -21.4% |
| Q1 2016 | $101,000 | -12.2% | 98,917 | +11.7% | 0.01% | -6.7% |
| Q4 2015 | $115,000 | +62.0% | 88,517 | +89.5% | 0.02% | +36.4% |
| Q3 2015 | $71,000 | -58.2% | 46,717 | -26.8% | 0.01% | -60.7% |
| Q2 2015 | $170,000 | +5.6% | 63,817 | -16.5% | 0.03% | +33.3% |
| Q1 2015 | $161,000 | – | 76,417 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,501,000 | $2,432,000 | 0.47% |
| Senvest Management, LLC | 2,278,995 | $3,692,000 | 0.26% |
| Opaleye Management Inc. | 250,000 | $405,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 928,758 | $1,505,000 | 0.05% |
| Benchmark Capital Advisors | 40,000 | $65,000 | 0.04% |
| Orbimed Advisors | 1,135,000 | $1,839,000 | 0.02% |
| NEXT Financial Group, Inc | 28,500 | $46,000 | 0.02% |
| Cutter & CO Brokerage, Inc. | 10,000 | $16,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 110 | $0 | 0.00% |
| Renaissance Technologies | 26,878 | $44,000 | 0.00% |